ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

QNTA Quanta Inc (CE)

0.0001
0.00 (0.00%)
May 22 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Share Name Share Symbol Market Stock Type
Quanta Inc (CE) QNTA OTCMarkets Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0001 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.0001
Trades Shares Traded Average Volume
0 0.00 -
Last Trade Type Quantity Price Currency
- 0 US$ 0.0001 USD

Quanta Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 50.56k 505.63M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Quanta (CE) News

Real-Time news about Quanta Inc (CE) (OTCMarkets): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QNTA Message Board. Create One! See More Posts on QNTA Message Board See More Message Board Posts

Historical QNTA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.0950.0980.00010.02103752,656,949-0.0949-99.89%
5 Years1.8319.000.00010.04751451,861,844-1.83-99.99%

Quanta (CE) Description

Quanta Inc., an applied science company, focuses on enhancing energy levels in plant matter to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Through its subsidiary, Medolife Rx, Inc., the company's lead clinical development program includes Escozine, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. Medolife Rx has also launched the Immunapen line of immune system enhancers, which meet the needs of people that want to stay healthy, while providing additional benefits such as reduction in anxiety or stress, as well as increased energy and focus.

Your Recent History

Delayed Upgrade Clock